Loading...

SRPT SAREPTA THERAPEUTICS INC Earnings Reports 8-K Filing

SRPT

SRPT

SAREPTA THERAPEUTICS INC

(SRPT)

2026 8-K

CEO Retirement Announcement

Financial Results Released

Business Update

Debt Exchange Agreement

Convertible Notes Exchange

CEO Equity Grant

Financial Results Announced

Convertible Notes Exchange

Debt Exchange Agreement

Management Change

Clinical Trials

Reduction in Force

Rights Offerings

Earnings Announcement

Credit Agreement

Financial Results

Collaboration Agreement

Amendment to Incentive Plan

Financial Results

FDA Approval of ELEVIDYS

Annual Meeting Results

External Links:

On January 12, 2026, Sarepta Therapeutics, Inc. released preliminary financial information for the year and quarter ending December 31, 2025, in connection with the J.P. Morgan Healthcare Conference. This event is considered significant for the company and has a neutral sentiment from an investor's perspective.

AI Assistant

SAREPTA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.